Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1/2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Recurrence 1Malignant Neoplasms of Independent (Primary) Multiple Sites 1Locally Advanced Colorectal Cancer 1Hand-Foot Syndrome 1Gene Mutation-Related Cancer 1Fatigue 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Medicine, Chinese Traditional × Clear all
NCT07344974 2026-01-20

Hand and Foot Bath for Taxane-Induced Peripheral Neurotoxicity

Peking University Cancer Hospital & Institute

Phase 4 Not yet recruiting
78 enrolled
Breast

Breast Neoplasms

NCT00028977 2012-09-17

Herbal Therapy in Treating Women With Metastatic Breast Cancer

University of California, San Francisco

Phase 1/2 Completed
21 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡